Stephan Lobitz
Impact in
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
- Virus-based gene therapy research
- Hematology top 5%
- Iron Metabolism and Disorders
Papers in ⓘ
- Genetics 17
- Hemoglobinopathies and Related Disorders 17
- Hematology 14
- Iron Metabolism and Disorders 12
- Blood groups and transfusion 6
- Co-authors
- Michael Angastiniotis (1 shared paper)Eunike Velleuer (1 shared paper)Helmut Hanenberg (4 shared papers)Detlev Schindler (2 shared papers)Holger N. Lode (2 shared papers)Sarah Herterich (1 shared paper)Holger Hoehn (1 shared paper)Ralf Dietrich (1 shared paper)
- Journals
- Blood (3 papers)International Journal of Neonatal Screening (3 papers)Cytogenetic and Genome Research (2 papers)Annals of Hematology (2 papers)Cancer Letters (2 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Stephan Lobitz
34 papers receiving 789 citations
Peers
Comparison fields: 5 of 88
- Genetics 218
- Hematology 214
- Cancer Research 128
- Biotechnology 60
- Molecular Biology 435
Countries citing papers authored by Stephan Lobitz
This map shows the geographic impact of Stephan Lobitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Lobitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Lobitz more than expected).
Fields of papers citing papers by Stephan Lobitz
This network shows the impact of papers produced by Stephan Lobitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Lobitz. The network helps show where Stephan Lobitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephan Lobitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 128 | |
| 2 | 2008 | 80 | |
| 3 | 2002 | 71 | |
| 4 | 2009 | 70 | |
| 5 | 2019 | 66 | |
| 6 | 2006 | 62 | |
| 7 | 2004 | 56 | |
| 8 | 2013 | 54 | |
| 9 | 2017 | 24 | |
| 10 | 2018 | 22 | |
| 11 | 2019 | 19 | |
| 12 | Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature. | 2006 | 19 |
| 13 | 2019 | 18 | |
| 14 | 2014 | 17 | |
| 15 | 2014 | 15 | |
| 16 | 2016 | 15 | |
| 17 | 2022 | 15 | |
| 18 | 2003 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2017 | 9 |
About Stephan Lobitz
Stephan Lobitz is a scholar working on Genetics, Hematology, Clinical Biochemistry, Family Practice and Biotechnology, having authored 34 papers that have together received 822 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (17 papers), Iron Metabolism and Disorders (12 papers), Blood groups and transfusion (6 papers), DNA Repair Mechanisms (6 papers), Metabolism and Genetic Disorders (4 papers), CRISPR and Genetic Engineering (4 papers), Prenatal Screening and Diagnostics (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Genetics (218 citations), Hematology (214 citations), Cancer Research (128 citations), Biotechnology (60 citations) and Molecular Biology (435 citations). Stephan Lobitz has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Michael Angastiniotis, Eunike Velleuer, Helmut Hanenberg, Detlev Schindler, Holger N. Lode, Sarah Herterich, Holger Hoehn, Ralf Dietrich, Bernd Gruhn and Richard Friedl. Their work appears in journals such as Blood, International Journal of Neonatal Screening, Cytogenetic and Genome Research, Annals of Hematology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.